MDBH

MDB Capital Holdings LLC-A

• PUBT·07/01 20:32

  Exozymes prices registered direct offering at USD 18 per unit, raising USD 639,990 gross

• PUBT·06/04 17:05

  PatentVest report maps muscle-preservation drug programs expanding GLP-1 obesity market opportunity

• PUBT·06/03 20:07

  MDB Capital set to present at Planet MicroCap Las Vegas conference

• PUBT·05/14 20:15

  MDB Capital net loss widens to USD 6.74 million in Q1 2026

• PUBT·05/09 00:15

  MDB Capital Holdings director Daniel Torpey files initial beneficial ownership statement

• PUBT·05/08 14:30

  PatentVest maps triple-agonist obesity drug pipeline, flags emerging patent battle

• PUBT·04/29 15:00

  MDB Capital report says retatrutide hits 28.7% weight loss, shifts obesity drug race to IP

• Reuters·04/09 21:01

  MDB Capital director Terry Jeb Barton Sr. files initial beneficial ownership statement

• TipRanks·04/06 00:27

  MDB Capital Holdings Bets on AI-Fueled Launch Surge

• Reuters·03/31 22:51

  PatentVest report flags $19B amylin drug deal boom in obesity treatment race

• Reuters·03/31 22:17

  MDB Capital FY25 net loss widens to $21.3 million; fee income climbs to $4.3 million

• Seeking Alpha·03/31 20:40

  MDB Capital Holdings reports FY results

• Benzinga·03/31 20:27

  MDB Capital Holdings Q4 EPS $0.04 Up From $(1.26) YoY

• Reuters·03/31 20:10

  MDB Capital announces availability of 2025 annual shareholder letter

• Reuters·03/31 20:05

  MDB CAPITAL HOLDINGS PROVIDES 2025 FULL YEAR UPDATE AND SHAREHOLDER LETTER